Whereas HDAC1 inhibition has been shown to directly affect GLI acetylation20, genetically based elimination or chemical inhibition of HDAC6 with selective small molecules is sufficient to block a subset of GLI transcriptional targets and SMO-M2-driven medulloblastoma growth in vivo33. The gene discussed is SMO; the disease is medulloblastoma.